Navigation Links
David Hsia, Ph.D. Joins Kinex Pharmaceuticals' Board of Directors
Date:9/15/2008

BUFFALO, N.Y., Sept. 15 /PRNewswire/ -- Kinex Pharmaceuticals announced that David Hsia, Ph.D. has been appointed to the Company's Board of Directors.

Dr. Hsia is a pharmaceutical veteran. He is a co-founder of Watson Pharmaceuticals, a publicly traded company listed in New York Stock Exchange (ticker: WPI). He was formerly Senior Vice President, Scientific Affairs of Watson Pharmaceuticals before his retirement. He has been involved in the development of various pharmaceutical formulations for over twenty years. Dr. Hsia received a Ph.D. in Industrial and Physical Pharmacy from Purdue University in 1975.

"Dr. Hsia is well known for his expertise in pharmaceutical development in our industry," commented Dr. Allen Barnett, Chief Executive Officer of Kinex Pharmaceuticals. "As the Company moves forward, we look forward to leveraging the full breadth of David's expertise as a Board member to assist us in developing our new drug candidates," Commented Dr. Johnson Lau, Executive Chairman of the Board.

"I am delighted to have a chance to work with the team at Kinex. The company's pipeline is very strong and I am glad to have this opportunity to assist to further advance their product pipeline," commented Dr. Hsia.

About Kinex Pharmaceuticals

Kinex is a drug discovery and development company that is focused on the use of its platform technology and compound libraries to identify and develop peptide-competitive kinase inhibitors. The Company's clinical compound KX2-391 is a selective Src kinase inhibitor that is currently in Phase 1 trials for oncology. Kinex's pipeline is focused on selective inhibitors for kinase targets that are important in oncology and inflammation and immunology. The Company is located in the New York State Center of Excellence in Bioinformatics and Life Sciences, on the Buffalo Niagara Medical Campus in Buffalo, New York.


'/>"/>
SOURCE Kinex Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
2. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
3. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
4. Omeros Appoints David A. Mann to its Board of Directors
5. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
6. David Farhadi, M.D. to Join Alger as Vice President, Senior Analyst/Co-Portfolio Manager
7. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
8. David M. Stout Joins NanoBio Corporations Board of Directors
9. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
10. Abingworth Appoints David Mayer as Partner
11. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Sequenom, Inc. (NASDAQ: SQNM ... lives through the development of innovative products and services, ... the United States denied its petition to ... of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") are ... by the Supreme Court,s Mayo Collaborative Services v. Prometheus ...
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and ... clinical trial team. , Using the CONSULT module, patients and physicians can schedule a ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):